| 1 | [SID56316484] | Active | Potency | 0.7079 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 2 | [SID56316484] | Active | Potency | 0.7079 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 3 | [SID56316484] | Active | Potency | 0.8191 | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen [AID686980, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 0.8191 [uM] | | BioAssay | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen | | AID | 686980 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 4 | [SID56316484] | Active | Potency | 0.8437 | qHTS Assay for the Inhibitors of L3MBTL1: Hit Validation [AID540279, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 0.8437 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1: Hit Validation | | AID | 540279 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 5 | [SID56316484] | Active | Potency | 0.8437 | qHTS Assay for the Inhibitors of L3MBTL1: Hit Validation [AID540279, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 0.8437 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1: Hit Validation | | AID | 540279 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 6 | [SID56316484] | Active | Potency | 1.0691 | Tb PFK orthogonal confirmatory assay using ATP depletion (Kinase-Glo Plus) as an alternative measure of Tb PFK activity: Hit Validation [AID504636, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 1.0691 [uM] | | BioAssay | Tb PFK orthogonal confirmatory assay using ATP depletion (Kinase-Glo Plus) as an alternative measure of Tb PFK activity: Hit Validation | | AID | 504636 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 7 | [SID56316484] | Active | IC50 | 1.42 | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence resonance energy transfer assay [AID624383, Type: confirmatory] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | IC50 | 1.42 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence resonance energy transfer assay | | AID | 624383 | | BioAssay type | confirmatory | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 8 | [SID56316484] | Active | Potency | 1.6944 | Inhibitors of T. brucei phosphofructokinase: Hit Validation [AID504637, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 1.6944 [uM] | | BioAssay | Inhibitors of T. brucei phosphofructokinase: Hit Validation | | AID | 504637 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 9 | [SID56316484] | Active | Potency | 2.5119 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 10 | [SID56316484] | Active | Potency | 2.5119 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 11 | [SID56316484] | Active | Potency | 3.1623 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 12 | [SID56316484] | Active | Potency | 3.1623 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 13 | [SID56316484] | Active | Potency | 3.7933 | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase [AID485367, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 3.7933 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase | | AID | 485367 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 14 | [SID56316484] | Active | Potency | 4.4668 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 15 | [SID56316484] | Active | Potency | 4.4668 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 16 | [SID56316484] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 17 | [SID56316484] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 18 | [SID56316484] | Active | Potency | 8.9125 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 19 | [SID56316484] | Active | Potency | 10 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 20 | [SID56316484] | Active | Potency | 10 | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 21 | [SID56316484] | Active | Potency | 11.4908 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 11.4908 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 22 | [SID56316484] | Active | Potency | 11.4908 | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation [AID588347, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 11.4908 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2: Hit confirmation | | AID | 588347 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 23 | [SID56316484] | Active | Potency | 39.8107 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 24 | [SID56316484] | Active | IC50 | 57.72 | Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents [AID1903, Type: confirmatory] | large T antigen [Simian virus 40] [gi:297591903] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | IC50 | 57.72 [uM] | | BioAssay | Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents | | AID | 1903 | | BioAssay type | confirmatory | | Target | large T antigen [Simian virus 40] [gi:297591903] | | PubMed | | | Data Table |  |
|
| 25 | [SID56316484] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 26 | [SID56316484] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493244, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493244 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 27 | [SID56316484] | Active | | | uHTS Colorimetric assay for identification of inhibitors of Scp-1 [AID493091, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | uHTS Colorimetric assay for identification of inhibitors of Scp-1 | | AID | 493091 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 28 | [SID56316484] | Active | | | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) [AID493160, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 493160 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 29 | [SID56316484] | Active | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] | | PubMed | | | Data Table |  |
|
| 30 | [SID56316484] | Active | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] | | PubMed | | | Data Table |  |
|
| 31 | [SID56316484] | Active | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 32 | [SID56316484] | Active | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 33 | [SID56316484] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 34 | [SID56316484] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) [AID492956, Type: screening] | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) | | AID | 492956 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase 2, cytoplasmic [Homo sapiens] [gi:4758878] | | PubMed | | | Data Table |  |
|
| 35 | [SID56316484] | Active | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 36 | [SID56316484] | Active | | | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID652036, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 652036 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 37 | [SID56316484] | Active | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 38 | [SID56316484] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID686964, Type: screening] | Methyl-CpG binding domain protein 2 [Homo sapiens] [gi:21595776] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide | | AID | 686964 | | BioAssay type | screening | | Target | Methyl-CpG binding domain protein 2 [Homo sapiens] [gi:21595776] | | PubMed | | | Data Table |  |
|
| 39 | [SID56316484] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 40 | [SID56316484] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 41 | [SID56316484] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 42 | [SID56316484] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 43 | [SID56316484] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID2176, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 2176 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 44 | [SID56316484] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID2176, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 2176 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 45 | [SID56316484] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 46 | [SID56316484] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 47 | [SID56316484] | Active | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 48 | [SID56316484] | Active | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 49 | [SID56316484] | Active | | | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). [AID2235, Type: screening] | PPP1CA gene product [Homo sapiens] [gi:56790945] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). | | AID | 2235 | | BioAssay type | screening | | Target | PPP1CA gene product [Homo sapiens] [gi:56790945] | | PubMed | | | Data Table |  |
|
| 50 | [SID56316484] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56316484 | | CID | 24979394 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|